Stealth BioTherapeutics (Stealth BioTherapeutics) Total Assets : $36.92 Mil (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Total Assets?

Stealth BioTherapeutics's Total Assets for the quarter that ended in Mar. 2022 was $36.92 Mil.

Total Assets is connected with ROA %. Stealth BioTherapeutics's annualized ROA % for the quarter that ended in Mar. 2022 was -74.69%. Total Assets is also linked to Revenue through Asset Turnover. Stealth BioTherapeutics's Asset Turnover for the quarter that ended in Mar. 2022 was 0.00.

Stealth BioTherapeutics Total Assets Historical Data

The historical data trend for Stealth BioTherapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Total Assets Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Total Assets

Get a 7-Day Free Trial

7.16

15.52

52.74

35.85

50.23

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Total Assets	Get a 7-Day Free Trial															34.78	32.26	44.19	50.23	36.92

Stealth BioTherapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Stealth BioTherapeutics's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets	=	Total Equity (A: Dec. 2021 )	+	Total Liabilities (A: Dec. 2021 )
	=	-45.295	+	95.521
	=	50.23

Stealth BioTherapeutics's Total Assets for the quarter that ended in Mar. 2022 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2022 )	+	Total Liabilities (Q: Mar. 2022 )
	=	-52.317	+	89.232
	=	36.92

Stealth BioTherapeutics (NAS:MITO) Total Assets Explanation

Total Assets is connected with ROA %.

Stealth BioTherapeutics's annualized ROA % for the quarter that ended in Mar. 2022 is

ROA %	=	Net Income (Q: Mar. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Mar. 2022 ))	/ count )
	=	-32.544	/	( (50.226	+	36.915)	/ 2 )
	=	-32.544	/	43.5705
	=	-74.69 %

Note: The Net Income data used here is four times the quarterly (Mar. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Stealth BioTherapeutics's Asset Turnover for the quarter that ended in Mar. 2022 is

	Asset Turnover
=	Revenue (Q: Mar. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Mar. 2022 ))	/ count )
=	0	/	( (50.226	+	36.915)	/ 2 )
=	0	/	43.5705
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Stealth BioTherapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.